Safety and Efficacy of Sustained Erythropoietin Therapy of Anemia in End Stage Renal Disease (ESRD) Dialysis Patients Using EPODURE Biopump

Trial Profile

Safety and Efficacy of Sustained Erythropoietin Therapy of Anemia in End Stage Renal Disease (ESRD) Dialysis Patients Using EPODURE Biopump

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 15 May 2014

At a glance

  • Drugs MDGN 201 (Primary)
  • Indications Anaemia
  • Focus Therapeutic Use
  • Sponsors Aevi Genomic Medicine
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 15 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top